| FTHFX | WSCOX | FTHFX / WSCOX | |
| Total Expense Ratio | 0.63 | 0.60 | 105% |
| Annual Report Gross Expense Ratio | 0.63 | 0.96 | 66% |
| Fund Existence | 14 years | 11 years | - |
| Gain YTD | 9.996 | 17.086 | 59% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11.1B | 117M | 9,487% |
| Annual Yield % from dividends | 0.70 | 0.31 | 224% |
| Returns for 1 year | -5.33 | 4.33 | -123% |
| Returns for 3 years | 41.85 | 38.93 | 107% |
| Returns for 5 years | 86.83 | 69.53 | 125% |
| Returns for 10 years | 172.84 | -32.62 | -530% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 79.26 | 0.71 | +0.90% |
| Janus Henderson Global Life Sciences A | |||
| ACVUX | 11.40 | 0.09 | +0.80% |
| American Century International Value I | |||
| TBWCX | 21.11 | 0.16 | +0.76% |
| Thornburg Better World International C | |||
| ABYEX | 10.38 | 0.01 | +0.10% |
| AB Emerging Markets Multi-Asset Advisor | |||
| PCSGX | 15.29 | 0.01 | +0.07% |
| PACE Small/Medium Co Growth Equity P | |||